Alpharma, established in 2013 in Nanjing, China, is a biopharmaceutical company focusing on developing and commercialization of human cardiomyocytes derived from pluripotent stem cells. We have a two pronged business models: 1. We provide human cardiomyocytes as research supplies in cardiotoxicity analysis of drug development. 2. We are developing cell transplantation therapy for Myocardial Infarction (MI, heart attack)
Company Details
- Employees
- 1
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- AMMED Soluciones Biomédicas.
Alpharma Bio Questions
Alpharma Bio's LinkedIn profile is https://www.linkedin.com/company/baishou
Alpharma Bio has
1 employees.
View email and phone details for 1
employees at Alpharma Bio.
Alpharma Bio's industry is
Biotechnology Research
Alpharma Bio's top competitors are
Ammed Soluciones Biomédicas,
Biogentac,
Laboratorios Kener, S.a. De C.v.,
Genbio,
Alpharma,
Biogentec,
Alpharma,
Laboratorios Alpharma,
Expertcell S.a. De C.v.,
Neolpharma Sa De Cv.
Alpharma Bio's categories are Biotechnology Research
